Skip to main content

Table 3 Post-treatment changes in IPSS

From: Iodine-125 seed brachytherapy for early stage prostate cancer: a single-institution review

 

No. of pts. (%)

IPSS (mean ± SD)

Included patients

118 (100%)

11.2 ± 5.1

≥ 5-point increase at 1.5 months

70 (59%)

6.8 ± 3,3

≥ 5-point decrease after 1.5 months

45 (38%)

4.6 ± 2.1

  1. IPSS: International prostate symptom score, SD: Standard deviation.